These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain. Zekry O; Gibson SB; Aggarwal A J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):91-8. PubMed ID: 27092576 [TBL] [Abstract][Full Text] [Related]
46. The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial. Knyahnytska Y; Zomorrodi R; Kaster T; Voineskos D; Trevizol A; Blumberger D JMIR Res Protoc; 2022 Jan; 11(1):e30163. PubMed ID: 34882570 [TBL] [Abstract][Full Text] [Related]
47. Acute and preventive pharmacologic treatment of cluster headache. Francis GJ; Becker WJ; Pringsheim TM Neurology; 2010 Aug; 75(5):463-73. PubMed ID: 20679639 [TBL] [Abstract][Full Text] [Related]
48. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477 [TBL] [Abstract][Full Text] [Related]
49. Intranasal Ketamine for Treatment of Acute Pain in Pediatrics: A Systematic Review. Ferguson CL; Beckett RD Pediatr Emerg Care; 2020 Aug; 36(8):e476-e481. PubMed ID: 32665505 [TBL] [Abstract][Full Text] [Related]
50. Individualizing treatment with verapamil for cluster headache patients. Blau JN; Engel HO Headache; 2004; 44(10):1013-8. PubMed ID: 15546265 [TBL] [Abstract][Full Text] [Related]
51. Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache. Kudrow D; Andrews JS; Rettiganti M; Oakes T; Bardos J; Gaul C; Riesenberg R; Wenzel R; Kuruppu D; Martinez J Headache; 2020 Nov; 60(10):2254-2264. PubMed ID: 33179263 [TBL] [Abstract][Full Text] [Related]
52. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Miller JP; Schauer SG; Ganem VJ; Bebarta VS Am J Emerg Med; 2015 Mar; 33(3):402-8. PubMed ID: 25624076 [TBL] [Abstract][Full Text] [Related]
53. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Ekbom K; Krabbe A; Micieli G; Prusinski A; Cole JA; Pilgrim AJ; Noronha D; Micelli G [corrected to Micieli G] Cephalalgia; 1995 Jun; 15(3):230-6. PubMed ID: 7553814 [TBL] [Abstract][Full Text] [Related]
54. Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial. Rabi J; Minori J; Abad H; Lee R; Gittler M Int J Pharm Compd; 2016; 20(6):517-520. PubMed ID: 28339391 [TBL] [Abstract][Full Text] [Related]
55. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study. Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ; Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728 [TBL] [Abstract][Full Text] [Related]
56. [Acute therapy of episodic and chronic cluster headache with sumatriptan s.c. Results of a one-year long-term study]. Göbel H; Lindner V; Pfaffenrath V; Ribbat M; Heinze A; Stolze H Nervenarzt; 1998 Apr; 69(4):320-9. PubMed ID: 9606683 [TBL] [Abstract][Full Text] [Related]
57. Intranasal Ketamine for Abortive Migraine Therapy in Pediatric Patients: A Single-Center Review. Turner AL; Shandley S; Miller E; Perry MS; Ryals B Pediatr Neurol; 2020 Mar; 104():46-53. PubMed ID: 31902550 [TBL] [Abstract][Full Text] [Related]
58. Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts. Ruscheweyh R; Broessner G; Goßrau G; Heinze-Kuhn K; Jürgens TP; Kaltseis K; Kamm K; Peikert A; Raffaelli B; Rimmele F; Evers S Cephalalgia; 2020 Dec; 40(14):1574-1584. PubMed ID: 32806953 [TBL] [Abstract][Full Text] [Related]
59. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
60. Open label study of intranasal sumatriptan (Imigran) for footballer's headache. McCrory P; Heywood J; Ugoni A Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]